This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Spectrazyme (2013-10-11)
- Starting date:
- October 11, 2013
- Posting date:
- October 21, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Natural health products
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-36329
Recalled Products
Spectrazyme
Reason
Voluntary recall initiated due to possible contamination. The product may contain the drug ingredient chloramphenicol.
Depth of distribution
Healthcare practitioners – British Columbia, Ontario, Alberta, Newfoundland and Labrador, Quebec
Affected products
Spectrazyme
DIN, NPN, DIN-HIM
NPN 80044751
Dosage form
Tablet
Strength
- Protease (10,000 PC)
- Papain (100,000 USP)
- Protease (20,000 HUT)
- Amylase (10,000 DU)
- Lipase (1,000 LU)
- Cellulase (1,000 CU)
- Peptidase (300 units)
- Maltase (300 DP)
- Lactase (200 Lac U)
- Invertase (200 Summer)
- Amla (Phylianthus emblica) (20mg)
Lot or serial number
- 0413083
Companies
- Recalling Firm
-
Metagenics Canada
851 Rangeview Road
Mississauga
L5E 1H1
Ontario
CANADA
- Marketing Authorization Holder
-
Metagenics Canada
851 Rangeview Road
Mississauga
L5E 1H1
Ontario
CANADA